- Home
- Case Studies
- How Atlas Travel Reduced Patient Dropout by 70% for a Phase III Clinical Trial
Life Sciences / Pharmaceutical
How Atlas Travel Reduced Patient Dropout by 70% for a Phase III Clinical Trial
The Results
70%
Reduction in patient withdrawal rates
$0
Patient out-of-pocket costs
100%
Sunshine Act reporting accuracy
Related Services
life-sciences
Ready to see results like these?
Talk to our team about optimizing your travel program.